(Q51007054)

26 March 2018

title

B cell biomarkers of rituximab responses in systemic lupus erythematosus. (English)

1 reference

26 March 2018

systemic lupus erythematosus

1 reference

0 references

1 reference

8

1 reference

26 March 2018

Paul Emery

9

object named as

Paul Emery

0 references

Frederique Ponchel

object named as

Frederique Ponchel

7

0 references

Maya Hema Buch

3

object named as

Maya H Buch

1 reference

26 March 2018

Edward M Vital

1

1 reference

26 March 2018

Shouvik Dass

2

1 reference

26 March 2018

Karen Henshaw

4

1 reference

26 March 2018

Colin T Pease

5

1 reference

26 March 2018

Michael F Martin

6

1 reference

26 March 2018

publication date

1 October 2011

1 reference

26 March 2018

published in

Arthritis & Rheumatology

1 reference

26 March 2018

volume

63

1 reference

26 March 2018

issue

10

1 reference

26 March 2018

page(s)

3038-3047

1 reference

26 March 2018

Systemic lupus erythematosus.

cites work

1 reference

Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks

21 January 2018

1 reference

Reduction of fatigue in Sjögren syndrome with rituximab: results of a randomised, double-blind, placebo-controlled pilot study.

21 January 2018

1 reference

Rituximab versus cyclophosphamide for ANCA-associated vasculitis

21 January 2018

1 reference

Rituximab in systemic lupus erythematosus: A systematic review of off-label use in 188 cases

21 January 2018

1 reference

B cell depletion therapy in systemic lupus erythematosus: long-term follow-up and predictors of response

21 January 2018

1 reference

Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II/III systemic lupus erythematosus evaluation of rituximab trial

21 January 2018

1 reference

Highly sensitive B cell analysis predicts response to rituximab therapy in rheumatoid arthritis

21 January 2018

1 reference

Eradication of minimal residual disease in B-cell chronic lymphocytic leukemia after alemtuzumab therapy is associated with prolonged survival

21 January 2018

1 reference

Management of nonresponse to rituximab in rheumatoid arthritis: predictors and outcome of re-treatment

21 January 2018

1 reference

B-cell depletion in the treatment of patients with systemic lupus erythematosus: a longitudinal analysis of 24 patients.

21 January 2018

1 reference

Rituximab and lupus: Good in real life, bad in controlled trials. comment on the article by Lu et al

21 January 2018

1 reference

Variability in the biological response to anti-CD20 B cell depletion in systemic lupus erythaematosus

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/ART.30466

1 reference

26 March 2018

Dimensions Publication ID

1011279699

0 references

1 reference

26 March 2018